STERLINBIO

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015'.

Sterling Biotech Limited has informed the Exchange regarding Intimation about Search and seizure operations conducted by the Directorate of Enforcement.

Sterling Biotech Limited has informed the Exchange vide letter dated March 24, 2014 regarding "Completion of Cashless Exchange Offer i.e. issue of Fresh Zero Coupon Foreign Currency Convertible Bonds due 2019 amounting to USD 206,464,000 (Fresh FCCBs) in cashless exchange of existing Zero Coupon Foreign Currency Convertible Bonds due 2012 (Existing Bonds), of which US$134,500,000 in Principal amount remained outstanding ("Cashless Exchange Offer")".

Sterling Biotech Limited has informed the Exchange that in respect of the US$250,000,000 Zero Coupon Convertible Bonds (the "Bonds") Due 2012 convertible into Ordinary shares or Global Depository Receipts representing Ordinary Shares of the Company of which US$134,500,000 in principal amount remain outstanding, to enable a consensual restructuring of the Bonds to be agreed and implemented, a meeting of the Bondholders was convened by the Trustee on May 30, 2013 at Hong Kong wherein an Extraordinary Resolution was passed suspending all litigations in India and UK.

Sterling Biotech Limited has informed the Exchange that Ms. Megha R. Chokshi, an assistant company secretary of the company has been designated as compliance officer in place of Mr. Kirtidev J. Khatri.

Sterling Biotech Limited has informed the Exchange that: "The following companies are now part of the Promoters Group of Sterling Biotech Limited ("the Company") with effect from March 28, 2008 as detailed below: 1) Eminence Trading Pvt. Ltd. holds 19,19,000 Equity shares (representing 0.84% of the Company). 2) Antariksha Securities Pvt. Ltd. holds 19,50,000 equity shares (representing 0.85% of the Company). 3) Marut Apparels Pvt. Ltd. holds 18,85,000 equity shares (representing 0.82% of the Company). With the above. promoters group shareholding stands at 8,90,34,694 equity shares of Rs.1/- ea

Sterling Biotech Limited has informed the Exchange that: The following Companies are now part of the Promoters Group of Sterling Biotech Limited with effect from March 27, 2008 as detailed below: (1) Swadeshi Finvest Pvt. Ltd. holds 15,38,000 equity shares (representing 0.67% of Sterling Biotech Equity Capital). (2) Sealord Erections Pvt. Ltd. holds 18,70,000 equity shares (representing 0.81% of Sterling Biotech Equity Capital). (3) Antariksha Capital and Finance (India) Pvt. Ltd. holds 19,00,000 equity shares (representing 0.83% of Sterling Biotech Equity Capital).With the above companies now